The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Yes, CDT sticking above 3.15 now with some reasonable small afternoon volumes. Very quiet during the East Coast AM .
Some west coast buying maybe?
I think a few things point to a possible ( and well overdue) re rating.
I feel weirdly optimistic. OMG did I really say that!
Yes not for smartphones. I realised you meant our board and stick with my question/comment. If any board did as you describe any excluded holders would have a case to consider action. Whatever we think of the investment decisions I think we should assume expect/assume integrity.
The whole recent and distant history with Mr Laiker and Vela seems too comp,ex for me to fathom.
But like you I’d love to be offered 0.04 for my holding. I’d even accept 0.039😀
You are maybe right Jace, some of these small firms do end up being forced to chase holders for TR1s, but an investor like him should know his rules and in any case why release before he hit 5 or dropped to 4, no need. We all need to go figure, or just see it as a bit of chaos.
The drop to 11/12 certainly encouraged some nice spring sale purchases. Let’s hope they do not turn out to be last seasons fashion. The big dumps are a concern or a sign. The portfolio is likely worth about 0.025 without doing too much analysis and if there is ever to be CDT news then it will likely move a lot and we can move a little.
All at Sea: sorry missed your question “ what did Virolens have to do with stadium?” . Answer: Everything. As the person running the project was the ex stadium CEO, and the person running manufacturing on Virolens was the ex Stadium COo/ops director!